GlaxoSmithKline Pakistan Statistics

Total Valuation

GlaxoSmithKline Pakistan has a market cap or net worth of PKR 67.97 billion. The enterprise value is 65.05 billion.

Market Cap	67.97B
Enterprise Value	65.05B

Important Dates

The next estimated earnings date is Tuesday, October 29, 2024.

Earnings Date	Oct 29, 2024
Ex-Dividend Date	n/a

Share Statistics

GlaxoSmithKline Pakistan has 318.47 million shares outstanding. The number of shares has increased by 0.01% in one year.

Shares Outstanding	318.47M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	5.57%
Float	318.25M

Valuation Ratios

The trailing PE ratio is 27.08.

PE Ratio	27.08
Forward PE	n/a
PS Ratio	1.23
PB Ratio	3.06
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	25.92
EV / Sales	1.18
EV / EBITDA	12.20
EV / EBIT	15.20
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	0.03
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	12.40%
Revenue Per Employee	32.51M
Profits Per Employee	1.48M
Employee Count	1,700
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +180.82% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+180.82%
50-Day Moving Average	166.52
200-Day Moving Average	120.10
Relative Strength Index (RSI)	76.82
Average Volume (20 Days)	358,000

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, GlaxoSmithKline Pakistan had revenue of PKR 55.27 billion and earned 2.51 billion in profits. Earnings per share was 7.88.

Revenue	55.27B
Gross Profit	7.32B
Operating Income	4.28B
Pretax Income	4.64B
Net Income	2.51B
EBITDA	5.32B
EBIT	4.28B
Earnings Per Share (EPS)	7.88

Full Income Statement

Balance Sheet

The company has 3.07 billion in cash and 153.14 million in debt, giving a net cash position of 2.92 billion or 9.17 per share.

Cash & Cash Equivalents	3.07B
Total Debt	153.14M
Net Cash	2.92B
Net Cash Per Share	9.17
Equity (Book Value)	22.24B
Book Value Per Share	69.84
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.25%, with operating and profit margins of 7.74% and 4.54%.

Gross Margin	13.25%
Operating Margin	7.74%
Pretax Margin	8.40%
Profit Margin	4.54%
EBITDA Margin	9.62%
EBIT Margin	7.74%
FCF Margin	n/a

Dividends & Yields

GlaxoSmithKline Pakistan does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	-0.01%
Earnings Yield	3.69%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on April 18, 2014. It was a forward split with a ratio of 1.1.

Last Split Date	Apr 18, 2014
Split Type	Forward
Split Ratio	1.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a